Advancing ADMET prediction through multiscale fragment-aware pretraining with MSformer-ADMET

Absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties are critical determinants of the pharmacokinetic and safety profiles of drug candidates. Accurate and early-stage prediction of ADMET characteristics is essential for reducing late-stage attrition rates, lowering development costs, and accelerating the drug discovery process. Recent advances in deep learning have shown great promise in molecular property prediction, especially with the emergence of Transformer-based architectures that can effectively model long-range dependencies in molecular representations. However, most existing methods rely heavily on atom-level encodings (e.g. smiles or molecular graphs), which often lack structural interpretability and generalization across heterogeneous tasks. Previously, we developed a de novo and flexible molecular representation framework named MSformer (available at https://github.com/ZJUFanLab/MSformer), which demonstrated success in bioactivity prediction. We have now adapted and specialized this architecture for ADMET property prediction. This adapted implementation, designated as MSformer-ADMET, extends the framework's capabilities to pharmacokinetic and toxicity endpoints while maintaining its flexible, fragmentation-based approach to molecular representation learning. MSformer-ADMET is fine-tuned on 22 tasks collected from the Therapeutics Data Commons (TDC), covering both classification and regression settings. Results demonstrate that MSformer-ADMET achieves superior performance across a wide range of ADMET endpoints, consistently outperforming conventional smiles-based and graph-based models. Notably, we further conducted interpretability analyses by leveraging the model's attention distributions and fragment-to-atom mappings, allowing the identification of key structural fragments that are highly associated with molecular properties. This post hoc interpretability provides more transparent insights into the structure-property relationship. Collectively, results demonstrate that MSformer-ADMET is a highly effective and broadly applicable model for ADMET prediction.

Authors

Institutions

Publication Details

Journal
Briefings in Bioinformatics
Published
2025-08-31
DOI
https://doi.org/10.1093/bib/bbaf506
Citations
1
Primary Topic
Machine Learning in Materials Science
Type
article
Field-Weighted Citation Impact
0.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advancing ADMET prediction through multiscale fragment-aware pretraining with MSformer-ADMET

Xiaohui Fan, Xin Shao, Yugang Lin, Chen Qian et al.
1 citations
Briefings in Bioinformatics
Machine Learning in Materials Science
0.52
article

Advancing ADMET prediction through multiscale fragment-aware pretraining with MSformer-ADMET

Xiaohui Fan, Xin Shao, Yugang Lin, Chen Qian, Yanrong Zheng, Haoran Li, Shuyang Nie, Minjie Shen, Tianyi Ma, Bingjie Zhu, Huihui Liu
article en
1 citations

Abstract

Absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties are critical determinants of the pharmacokinetic and safety profiles of drug candidates. Accurate and early-stage prediction of ADMET characteristics is essential for reducing late-stage attrition rates, lowering development costs, and accelerating the drug discovery process. Recent advances in deep learning have shown great promise in molecular property prediction, especially with the emergence of Transformer-based architectures that can effectively model long-range dependencies in molecular representations. However, most existing methods rely heavily on atom-level encodings (e.g. smiles or molecular graphs), which often lack structural interpretability and generalization across heterogeneous tasks. Previously, we developed a de novo and flexible molecular representation framework named MSformer (available at https://github.com/ZJUFanLab/MSformer), which demonstrated success in bioactivity prediction. We have now adapted and specialized this architecture for ADMET property prediction. This adapted implementation, designated as MSformer-ADMET, extends the framework's capabilities to pharmacokinetic and toxicity endpoints while maintaining its flexible, fragmentation-based approach to molecular representation learning. MSformer-ADMET is fine-tuned on 22 tasks collected from the Therapeutics Data Commons (TDC), covering both classification and regression settings. Results demonstrate that MSformer-ADMET achieves superior performance across a wide range of ADMET endpoints, consistently outperforming conventional smiles-based and graph-based models. Notably, we further conducted interpretability analyses by leveraging the model's attention distributions and fragment-to-atom mappings, allowing the identification of key structural fragments that are highly associated with molecular properties. This post hoc interpretability provides more transparent insights into the structure-property relationship. Collectively, results demonstrate that MSformer-ADMET is a highly effective and broadly applicable model for ADMET prediction.

Briefings in BioinformaticsVol. 26(5)
Zhejiang Chinese Medical University (CN), Ministry of Education (KR), Jinhua Academy of Agricultural Sciences (CN), Zhejiang Pharmaceutical College (CN), Jinhua Central Hospital (CN), Zhejiang University of Technology (CN), Zhejiang University (CN)
National Natural Science Foundation of China, National Science and Technology Major Project, Natural Science Foundation of Zhejiang Province
Openalex Percentile: Top 32%
Machine Learning in Materials Science
0.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.